Detalles de la búsqueda
1.
Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
Cancer
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718047
2.
First-in-human study of ONO-4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors.
Cancer Sci
; 114(1): 211-220, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082616
3.
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer.
Breast Cancer Res Treat
; 197(3): 593-602, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494460
4.
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 1011-1020, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35932386
5.
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
Oncology
; 100(7): 370-375, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405680
6.
Management of breast cancer in older patients.
Jpn J Clin Oncol
; 52(7): 682-689, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462408
7.
Atherosclerotic Progression Is Related to Immune-Related Adverse Events.
Int Heart J
; 63(2): 293-298, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354749
8.
First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors.
Cancer Sci
; 112(4): 1514-1523, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615628
9.
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Breast Cancer Res Treat
; 186(1): 135-147, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259001
10.
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
Invest New Drugs
; 39(6): 1559-1567, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117970
11.
Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers.
BMC Cancer
; 21(1): 1131, 2021 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34670536
12.
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.
BMC Cancer
; 21(1): 1269, 2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819039
13.
A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).
Jpn J Clin Oncol
; 51(9): 1471-1474, 2021 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215870
14.
The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.
Jpn J Clin Oncol
; 51(5): 693-699, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33621324
15.
[Clinical Application of Liquid Biopsy for Breast Cancer Diagnosis and Treatment].
Gan To Kagaku Ryoho
; 48(10): 1197-1202, 2021 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-34657047
16.
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors.
Cancer Sci
; 111(2): 571-579, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797489
17.
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer.
Breast Cancer Res Treat
; 180(3): 687-694, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140811
18.
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy.
Breast Cancer Res Treat
; 181(2): 323-329, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314111
19.
BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma.
Mod Pathol
; 33(9): 1660-1668, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238877
20.
Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.
Invest New Drugs
; 38(2): 468-477, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124055